MIA
TMO icon

MeadowBrook Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

MeadowBrook Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Sell
2,975
-35
-1% -$16.8K 1.18% 22
2026
Q1 		$1.48M Buy
3,010
+90
+3% +$48.8K 1.31% 17
2025
Q4 		$1.69M Sell
2,920
-50
-2% -$28.3K 1.44% 13
2025
Q3 		$1.44M Sell
2,970
-32
-1% -$14.9K 1.24% 16
2025
Q2 		$1.22M Buy
3,002
+12
+0.4% +$5.02K 1.09% 19
2025
Q1 		$1.49M Sell
2,990
-145
-5% -$78.5K 1.39% 14
2024
Q4 		$1.63M Sell
3,135
-12
-0.4% -$6.6K 1.45% 14
2024
Q3 		$1.95M Sell
3,147
-10
-0.3% -$5.92K 1.76% 12
2024
Q2 		$1.75M Sell
3,157
-14
-0.4% -$8.02K 1.65% 12
2024
Q1 		$1.84M Sell
3,171
-265
-8% -$149K 1.72% 13
2023
Q4 		$1.82M Buy
+3,436
New +$1.66M 1.74% 11

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

MeadowBrook Investment Advisors's TMO Position: Q2 2026 in Review

MeadowBrook Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $16.8K and leaving 2,975 shares worth $1.49M. The position accounts for 1.18% of the portfolio, ranked #22.

MeadowBrook Investment Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.95M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MeadowBrook Investment Advisors held 2,975 shares of Thermo Fisher Scientific worth $1.49M as of Q2 2026.
  • MeadowBrook Investment Advisors sold 35 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.8K.
  • Thermo Fisher Scientific made up 1.18% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #22 holding.
  • MeadowBrook Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's Thermo Fisher Scientific position peaked at $1.95M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.